Medicine Overview of Meflotas Drop
Meflotas Drop is used in the treatment of malaria
Abdominal pain, Abnormal dreams, Anxiety, Chills, Depression, Diarrhoea, Dizziness, Fever, Headache, Altered heart rate, Insomnia (difficulty in sleeping), Itching, Loss of appetite, Muscle pain, Nausea, Rash, Ringing in ear, Vertigo, Visual impairment, Vomiting, Fatigue.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a marked dropper and take it as directed. Meflotas Drop is to be taken with food.
Meflotas Drop is a weak base that reaches high concentration within the malarial parasite and causes accumulation of toxic heme pigment, which kills it.
In Depth Information on Meflotas Drop
- Consult your doctor before taking mefloquine if you have fits (seizures), any heart diseases or liver disorders.
- Seek immediate medical attention if you experience pain, burning, tingling, numbness in hands/feet and/or muscle weakness or problems in eyes or with vision after taking mefloquine.
- Do not drive or operate machinery while using mefloquine as it may cause dizziness and visual disturbances.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Meflotas Drop related warnings
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Meflotas Drop may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Meflotas Drop is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Meflotas Drop can cause dizziness, loss of balance and mental problems and this may affect your ability to drive.
There is limited information available on the use of Meflotas Drop in patients with kidney disease. Please consult your doctor.
Meflotas Drop should be used with caution in patients with liver disease. Dose adjustment of Meflotas Drop may be needed. Please consult your doctor.
Use of Meflotas Drop is not recommended in patients with severe liver disease.
Frequently asked questions about Meflotas Drop
Yes. Meflotas is safe if used at the prescribed doses for the prescribed duration as advised by your doctor
It is not recommended for use in babies below 3 months and weighing less than 5 kg
Q. Is mefloquine an antibiotic/ a quinolone/ does it contain sulphur or sulfa/ contain quinine?
No. Mefloquine is an antimalarial drug with activity against malaria causing parasites. It is a quinine antimalarial and does not contain sulphur/ sulfa or quinolone
Q. Is mefloquine the same as doxycycline/ chloroquine?
No. Mefloquine is not the same as doxycycline or chloroquine. All three drugs have different mechanism of action and indications
Meflotas is an antimalarial drug. It works by killing the malaria causing parasite by destroying the parasites at a crucial stage of development (asexual intraerythocytic stage)
Meflotas is used in the prevention and treatment of malaria
Yes. Insomnia (difficulty falling asleep) is a common side effect of Meflotas treatment
Yes. Studies have indicated that Meflotas is safe for use in glucose-6-phosphate dehydrogenase (G6PD) deficiency.
One of the following vendor pharmacies will deliver Meflotas Drop: BBS, SRG, ABP, DPL, CLT, ATP, SVH, AMR, UMP, JVO, NVY, JVN, MAK, GPT, SSA, ANT, AGT, ENP, DLP, RSA, SBL, BIO, VRS, HPC, OWP, HMP, OIP, AAY, PEN, TOM, DGN, TNH, MAX, KHH, USF, HBV, SHD, BDN, STA, PPR, SCH, SGC, HEX, LCC, GBL, SAF, RPP, JIV, DFP, OHM, ZEL, SDM, PVP, PLT, HAT, NVL, PNT, PTI, MPC, GNC, RSS, AVN, SWA, NSL, OLT, THP, MDO, SWP, JMJ, IAD, SYN, PRN, MMS, SAT, BMJ, RJH, RUS, LHA, EQN, RWP, SJP, WSI, HIP, ADT, NWP, ZVP, GPP, NNH, DPP, RKS, ARD, ATL, MAM, 9T9, NXG, RHW, SBA, BHP, BAL, AYU, PWN, SHP, MLC, DDR, FGH, GTK, EMB, MOM, RHL, AAR, INC, BTM, IPL, DYG, MSD, HGI, TRP, NTB, DHR, GTC, WHL, NDP, BSN